Combination treatment with methotrexate ( an antifolate drug which suppresses the immune system ) has been shown to reduce the formation of these antibodies in patients with rheumatoid arthritis and combination therapy with other immunosuppressants has been shown to reduce the likelihood of these antibodies being formed in Crohn's disease.
मोबाइल